Needham Reiterates Hold on Neurocrine Biosciencesto Hold

BenzingaDec 20 10:52 ET

Neurocrine Biosciences Analyst Ratings

BenzingaDec 20 10:50 ET · Ratings

Friday Opens With Falling Prices, but Market Turns Around | Live Stock

Kevin TraversDec 20 10:29 ET

Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership

BenzingaDec 19 16:24 ET

(GILD) - Analyzing Gilead Sciences's Short Interest

BenzingaDec 19 14:30 ET

Gilead Raises Assembly Bio Stake to ~30%

Seeking AlphaDec 19 10:42 ET